Plasma miR‐21 is a novel diagnostic biomarker for biliary tract cancer

Biliary tract cancer (BTC) has a generally poor prognosis. Furthermore, it is difficult to distinguish BTC from benign biliary disease (BBD) with commonly used modalities. Therefore, a novel biomarker to facilitate cancer detection is highly desirable. Recent studies have reported the use of circula...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Kishimoto, Tomoya, Eguchi, Hidetoshi, Nagano, Hiroaki, Kobayashi, Shogo, Akita, Hirofumi, Hama, Naoki, Wada, Hiroshi, Kawamoto, Koichi, Tomokuni, Akira, Tomimaru, Yoshito, Umeshita, Koji, Doki, Yuichiro, Mori, Masaki
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2013
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7653532/
https://ncbi.nlm.nih.gov/pubmed/24118467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12300
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars